期刊论文详细信息
Journal of Bone Oncology | |
Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers | |
Shin Takahashi1  Chikashi Ishioka1  Masanobu Takahashi1  Hideharu Yamada1  Hideki Shimodaira1  Kota Ohuchi2  Masahiro Takahashi2  Yoshinari Okada2  Hiroo Imai2  Ken Saijo2  Keigo Komine2  | |
[1] Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1, Seiryo-machi, Aobaku, Sendai 980-8575, Japan;Department of Medical Oncology, Tohoku University Hospital, 1-1, Seiryo-machi, Aobaku, Sendai 980-8547, Japan; | |
关键词: Denosumab; Zoledronic acid; Bone metastases; Gastrointestinal cancer; Pancreas-biliary system cancer; Rare cancers; | |
DOI : 10.1016/j.jbo.2016.10.002 | |
来源: DOAJ |
【 授权许可】
Unknown